# Samir Arora, MD – FDA Inspection, Feb 17, 2017

Source: https://www.keypedia.com/records/fda_inspections/samir-arora-md/f686b64a-dcfb-48a0-b67c-6703874e12f8
Source feed: FDA_Inspections

> FDA inspection 1001716 of Samir Arora, MD, February 17, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1001716
- Company Name: Samir Arora, MD
- Inspection Date: 2017-02-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Officers

- [Company Rep](https://www.keypedia.com/people/craig-t-rybus/246aad79-6370-42e2-af6e-c0079c1bcbc6)
- [Company Rep](https://www.keypedia.com/people/geoffrey-k-kilili/b00aeedf-95bd-4ccf-a23e-6e12e60249c4)

Company: https://www.keypedia.com/companies/samir-arora-md/8ea26a41-ef87-4674-b7a3-ccc74afc5c7e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d